A Rare Case of Thrombotic Thrombocytopenic Purpura Developed During Nivolumab Treatment in a Patient with Hodgkin Lymphoma
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Introduction: Nivolumab is an anti-PD-1 monoclonal antibody used in the treatment of relapsed/refractory Hodgkin lymphoma.Case: Herein, we present a rare case of TTP developed following nivolumab treatment in a patient with Hodgkin lymphoma.Conclusion: This case draws attention to hematological toxicities associated with immune checkpoint inhibitors.
